Answers are grounded in this paper and cite their sources.
Since the beginning of the COVID-19 pandemic, an increase in the delivery of psychotropic drugs has been observed. However, there are no more precise data to date on the profile of people affected by these changes in consumption. The aim of this study was therefore to assess its impact on the profile of psychotropic drug users. Two historical cohorts, a "COVID cohort" (2020-2021) and a "pre-COVID cohort" (2018-2019), were constituted from the National Health Data System (SNDS) database. Within each of these two cohorts, three distinct subpopulations were defined according to the presence of reimbursements for psychotropic drugs during year n-1 (no previous use population, low previous use population, high previous use population). Then we analyzed reimbursements for psychotropic drugs using a multichannel sequence analysis and performed clustering analysis of sequences. The clusters identified in the three sub-populations of the COVID cohort were broadly similar to the clusters identified in the three sub-populations of the pre-COVID cohort with equivalent proportions. However, the COVID cohort differs in some aspects from the pre-COVID cohort: (1) the loss of a cluster of hypnotic users in the low previous use population, (2) earlier and longer consumption of certain psychotropic drugs (antidepressants, anxiolytics) in some clusters of the no previous use and low previous use populations, (3) a higher proportion of individuals affiliated to a specific insurance plan for low-income patients in some clusters corresponding to psychiatric profiles thought to be more severe in the three sub-populations and (4) a change in the sex ratio in some clusters of the no previous use and low previous use populations. In addition to providing answers to the specific question of the impact of the Covid-19 health crisis on the profile of psychotropic drug users, this study highlights the interest and feasibility of the multichannel sequence analysis method in pharmaco-epidemiology.
No takes yet. Share an insight, caveat, or question.
Duval et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: